SMURF2 and breast cancer: As our data in the current study suggest that PIAS3 acts via sumoylation of Smurf2 to suppress the invasive behavior of breast cancer cell-derived organoids, it will be important in future studies to determine the role of PIAS3-Smurf2 sumoylation pathway in the metastatic potential of human breast cancer.